The 2,5 Oligoadenylate Synthetase/RNaseL pathway is a novel effector of BRCA1 - and interferon-gamma-mediated apoptosis
Data(s) |
18/08/2005
|
---|---|
Resumo |
I discovered that 2,5OAS family of proteins was transcriptionally upregulated by BRCA1 and interferon gamma in a synergistic manner. This correlated with synergistically induced apoptosis and both the induction of 2,5OAS and the accompanying apoptosis could be inhibited by 2,5OAS specific siRNA proving 2,5OAS was the apoptotic effector. |
Identificador |
http://dx.doi.org/10.1038/sj.onc.1208698 http://www.scopus.com/inward/record.url?scp=24644522875&partnerID=8YFLogxK |
Idioma(s) |
eng |
Direitos |
info:eu-repo/semantics/restrictedAccess |
Fonte |
Mullan , P , Kennedy , R , Buckley , N , O'Brien , J , Hosey , A , Johnston , P & Harkin , P 2005 , ' The 2,5 Oligoadenylate Synthetase/RNaseL pathway is a novel effector of BRCA1 - and interferon-gamma-mediated apoptosis ' Oncogene , vol 24(35) , no. 35 , pp. 5492-5501 . DOI: 10.1038/sj.onc.1208698 |
Palavras-Chave | #/dk/atira/pure/subjectarea/asjc/1300/1306 #Cancer Research #/dk/atira/pure/subjectarea/asjc/1300/1311 #Genetics #/dk/atira/pure/subjectarea/asjc/1300/1312 #Molecular Biology |
Tipo |
article |